JOINTSTEM
Sponsors
R-Bio, Nature Cell Co. Ltd.
Conditions
Degenerative ArthritisKnee ArthritisKnee OsteoarthritisOsteoarthritis, Knee
Phase 2
Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis
CompletedNCT02658344
Start: 2015-07-31End: 2016-12-31Updated: 2019-06-05
A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis
CompletedNCT02674399
Start: 2016-02-16End: 2018-12-28Updated: 2021-08-10
Follow-up Study for Participants Jointstem Clinical Trial
CompletedNCT03509025
Start: 2017-02-08End: 2020-12-09Updated: 2022-09-28
A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis
RecruitingNCT04368806
Start: 2021-05-26End: 2026-12-31Target: 140Updated: 2025-07-24
Phase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis
CompletedNCT03990805
Start: 2019-06-11End: 2020-12-15Updated: 2022-09-28
Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial
Active, not recruitingNCT04427930
Start: 2020-04-13End: 2027-12-30Updated: 2023-07-10
Unknown Phase
Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration
NCT04821102
Start: 2023-07-01End: 2024-12-31Target: 21Updated: 2022-09-28
Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy
Not yet recruitingNCT04825730
Start: 2023-12-01End: 2029-12-31Target: 14Updated: 2022-09-28